Kaustav Bera
7Patents
0h-index
6Co-inventors
27Inventor score
Filing activity: Nov 27, 2018 → Oct 12, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10839513B2 | Distinguishing hyperprogression from other response patterns to PD1/PD-L1 inhibitors in non-small cell lung cancer with pre-therapy radiomic features | Physics | 0 | Active |
| US11676703B2 | Combination of radiomic and pathomic features in the prediction of prognoses for tumors | Physics | 0 | Active |
| US11610304B2 | Predicting tumor prognoses based on a combination of radiomic and clinico-pathological features | Physics | 0 | Active |
| US11574404B2 | Predicting recurrence and overall survival using radiomic features correlated with PD-L1 expression in early stage non-small cell lung cancer (ES-NSCLC) | Physics | 0 | Active |
| US11350901B2 | Recurrence prognosis and prediction of added benefit of adjuvant chemotherapy in early stage non-small cell lung cancer with radiomic features on baseline computed tomography | Physics | 0 | Active |
| US11494900B2 | Prognosis of prostate cancer with computerized histomorphometric features of tumor morphology from routine hematoxylin and eosin slides | Physics | 0 | Active |
| US11464473B2 | Distinguishing minimally invasive carcinoma and adenocarcinoma in situ from invasive adenocarcinoma with intratumoral and peri-tumoral textural features | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.